Table 4. Unifactorial analysis of demographic and clinical characteristics in relation to paxillin positivity and IRS score.
All categorical variables were presented as frequencies (%). IRS: immunoreactive score.
| Variables | Paxillin positivity | p-value | Paxillin IRS score | p-value | |||
| Negative (n=73) | Positive (n=17) | No (n=74) | Weak-moderate (n=16) | ||||
| Age; mean ± SD | 60.16 ± 11.98 | 59.06 ± 16.96 | 0.753 | 60.15 ± 11.89 | 59.06 ± 17.52 | 0.763 | |
| Histologic type | Clear cell | 50 (86.2) | 8 (13.8) | 0.348 | 50 (86.2) | 8 (13.8) | 0.486 |
| Papillary | 11 (73.3) | 4 (26.7) | 11 (73.3) | 4 (26.7) | |||
| Chromophobe | 8 (72.7) | 3 (27.3) | 9 (81.8) | 2 (18.2) | |||
| Grade | 1 | 7 (77.8) | 2 (22.2) | 0.045 | 7 (77.8) | 2 (22.2) | 0.081 |
| 2 | 41 (91.1) | 4 (8.9) | 41 (91.1) | 4 (8.9) | |||
| 3 and 4 | 25 (69.4) | 11 (30.6) | 26 (72.2) | 10 (27.8) | |||
| Gender | Male | 53 (84.1) | 10 (15.9) | 0.378 | 20 (74.1) | 7 (25.9) | 0.231 |
| Female | 20 (74.1) | 7 (25.9) | 54 (85.7) | 9 (14.3) | |||
| Stage Τ | 1 | 52 (82.5) | 11 (17.5) | 0.044 | 52 (82.5) | 11 (17.5) | 0.113 |
| 2 | 11 (100) | 0 (0) | 11 (100.0) | 0 (0) | |||
| 3 | 10 (62.5) | 6 (37.5) | 11 (68.8) | 5 (31.3) | |||